KRAS c.310A>C ;(p.K104Q)

Variant ID: 12-25378688-T-G

NM_004985.3(KRAS):c.310A>C;(p.K104Q)

This variant was identified in 18 publications

View GRCh38 version.




Publications:


RAS-targeted cancer therapy: Advances in drugging specific mutations.

Medcomm
Liu, Cen C; Ye, Danyang D; Yang, Hongliu H; Chen, Xu X; Su, Zhijun Z; Li, Xia X; Ding, Mei M; Liu, Yonggang Y
Publication Date: 2023-06

Variant appearance in text: KRAS: K104Q
PubMed Link: 37250144
Variant Present in the following documents:
  • MCO2-4-e285.pdf
View BVdb publication page



Targeting small GTPases: emerging grasps on previously untamable targets, pioneered by KRAS.

Signal Transduction And Targeted Therapy
Yin, Guowei G; Huang, Jing J; Petela, Johnny J; Jiang, Hongmei H; Zhang, Yuetong Y; Gong, Siqi S; Wu, Jiaxin J; Liu, Bei B; Shi, Jianyou J; Gao, Yijun Y
Publication Date: 2023-05-23

Variant appearance in text: KRAS: K104Q
PubMed Link: 37221195
Variant Present in the following documents:
  • 41392_2023_Article_1441.pdf
View BVdb publication page



The Four Homeostasis Knights: In Balance upon Post-Translational Modifications.

International Journal Of Molecular Sciences
Pieroni, Stefania S; Castelli, Marilena M; Piobbico, Danilo D; Ferracchiato, Simona S; Scopetti, Damiano D; Di-Iacovo, Nicola N; Della-Fazia, Maria Agnese MA; Servillo, Giuseppe G
Publication Date: 2022-11-21

Variant appearance in text: KRAS: K104Q
PubMed Link: 36430960
Variant Present in the following documents:
  • ijms-23-14480.pdf
View BVdb publication page



Thermal Shift Assay for Small GTPase Stability Screening: Evaluation and Suitability.

International Journal Of Molecular Sciences
Kopra, Kari K; Valtonen, Salla S; Mahran, Randa R; Kapp, Jonas N JN; Hassan, Nazia N; Gillette, William W; Dennis, Bryce B; Li, Lianbo L; Westover, Kenneth D KD; Plückthun, Andreas A; Härmä, Harri H
Publication Date: 2022-06-26

Variant appearance in text: KRAS: K104Q
PubMed Link: 35806100
Variant Present in the following documents:
  • ijms-23-07095.pdf
View BVdb publication page



Oncogenic KRAS G12C: Kinetic and redox characterization of covalent inhibition.

The Journal Of Biological Chemistry
Huynh, Minh V MV; Parsonage, Derek D; Forshaw, Tom E TE; Chirasani, Venkat R VR; Hobbs, G Aaron GA; Wu, Hanzhi H; Lee, Jingyun J; Furdui, Cristina M CM; Poole, Leslie B LB; Campbell, Sharon L SL
Publication Date: 2022-08

Variant appearance in text: KRAS: K104Q
PubMed Link: 35753348
Variant Present in the following documents:
  • main.pdf
View BVdb publication page



Delineating the RAS Conformational Landscape.

Cancer Research
Parker, Mitchell I MI; Meyer, Joshua E JE; Golemis, Erica A EA; Dunbrack, Roland L RL
Publication Date: 2022-07-05

Variant appearance in text: KRAS: K104Q
PubMed Link: 35536216
Variant Present in the following documents:
  • can-22-0804_supplementary_datasets_s1-s4_suppsds1-sds4.xlsx, sheet 1
View BVdb publication page



Identification of New KRAS G12D Inhibitors through Computer-Aided Drug Discovery Methods.

International Journal Of Molecular Sciences
Kulkarni, Apoorva M AM; Kumar, Vikas V; Parate, Shraddha S; Lee, Gihwan G; Yoon, Sanghwa S; Lee, Keun Woo KW
Publication Date: 2022-01-24

Variant appearance in text: KRAS: K104Q
PubMed Link: 35163234
Variant Present in the following documents:
  • ijms-23-01309.pdf
View BVdb publication page



Identification of New KRAS G12D Inhibitors through Computer-Aided Drug Discovery Methods.

International Journal Of Molecular Sciences
Kulkarni, Apoorva M AM; Kumar, Vikas V; Parate, Shraddha S; Lee, Gihwan G; Yoon, Sanghwa S; Lee, Keun Woo KW
Publication Date: 2022-01-24

Variant appearance in text: KRAS: K104Q
PubMed Link: 35163234
Variant Present in the following documents:
  • ijms-23-01309.pdf
View BVdb publication page



KRAS K104 modification affects the KRASG12D-GEF interaction and mediates cell growth and motility.

Scientific Reports
Chen, Chih-Chieh CC; Hsu, Chia-Yi CY; Lin, Hsiao-Yun HY; Zeng, Hong-Qi HQ; Cheng, Kuang-Hung KH; Wu, Chia-Wei CW; Tsai, Eing-Mei EM; Hsieh, Tsung-Hua TH
Publication Date: 2020-10-15

Variant appearance in text: KRAS: K104Q
PubMed Link: 33060649
Variant Present in the following documents:
  • Main text
View BVdb publication page



KRAS Ubiquitination at Lysine 104 Retains Exchange Factor Regulation by Dynamically Modulating the Conformation of the Interface.

Iscience
Yin, Guowei G; Zhang, Jerry J; Nair, Vinay V; Truong, Vinh V; Chaia, Angelo A; Petela, Johnny J; Harrison, Joseph J; Gorfe, Alemayehu A AA; Campbell, Sharon L SL
Publication Date: 2020-08-10

Variant appearance in text: KRAS: K104Q
PubMed Link: 32882514
Variant Present in the following documents:
  • Main text
  • mmc1.pdf
  • main.pdf
View BVdb publication page



Dynamically encoded reactivity of Ras enzymes: opening new frontiers for drug discovery.

Cancer Metastasis Reviews
Pálfy, Gyula G; Menyhárd, Dóra K DK; Perczel, András A
Publication Date: 2020-12

Variant appearance in text: K-Ras4B: K104Q
PubMed Link: 32815102
Variant Present in the following documents:
  • Main text
  • 10555_2020_Article_9917.pdf
View BVdb publication page



Biology, pathology, and therapeutic targeting of RAS.

Advances In Cancer Research
Rhett, J Matthew JM; Khan, Imran I; O'Bryan, John P JP
Publication Date: 2020

Variant appearance in text: KRAS: K104Q
PubMed Link: 32723567
Variant Present in the following documents:
  • Main text
View BVdb publication page



KIAA1109 gene mutation in surviving patients with Alkuraya-Kučinskas syndrome: a review of literature.

Bmc Medical Genetics
Kumar, Kishore K; Bellad, Anikha A; Prasad, Pramada P; Girimaji, Satish Chandra SC; Muthusamy, Babylakshmi B
Publication Date: 2020-06-26

Variant appearance in text: KRAS: K104Q
PubMed Link: 32590954
Variant Present in the following documents:
  • 12881_2020_1074_MOESM1_ESM.xlsx, sheet 1
View BVdb publication page



PBRM1 acts as a p53 lysine-acetylation reader to suppress renal tumor growth.

Nature Communications
Cai, Weijia W; Su, Liya L; Liao, Lili L; Liu, Zongzhi Z ZZ; Langbein, Lauren L; Dulaimi, Essel E; Testa, Joseph R JR; Uzzo, Robert G RG; Zhong, Zhijiu Z; Jiang, Wei W; Yan, Qin Q; Zhang, Qing Q; Yang, Haifeng H
Publication Date: 2019-12-20

Variant appearance in text: KRAS: K104Q
PubMed Link: 31863007
Variant Present in the following documents:
  • 41467_2019_13608_MOESM2_ESM.pdf
View BVdb publication page



Therapeutic targeting of RAS: New hope for drugging the "undruggable".

Biochimica Et Biophysica Acta. Molecular Cell Research
Khan, Imran I; Rhett, J Matthew JM; O'Bryan, John P JP
Publication Date: 2020-02

Variant appearance in text: KRAS: K104Q
PubMed Link: 31678118
Variant Present in the following documents:
  • Main text
View BVdb publication page



Implications of the HDAC6-ERK1 feed-forward loop in immunotherapy.

Journal Of Immunological Sciences
Wu, Jheng-Yu JY; Moses, Niko N; Bai, Wenlong W; Zhang, Xiaohong Mary XM
Publication Date: 2018

Variant appearance in text: KRAS: K104Q
PubMed Link: 30854521
Variant Present in the following documents:
  • Main text
View BVdb publication page



K-Ras G-domain binding with signaling lipid phosphatidylinositol (4,5)-phosphate (PIP2): membrane association, protein orientation, and function.

The Journal Of Biological Chemistry
Cao, Shufen S; Chung, Stacey S; Kim, SoonJeung S; Li, Zhenlu Z; Manor, Danny D; Buck, Matthias M
Publication Date: 2019-04-26

Variant appearance in text: K-Ras4B: K104Q
PubMed Link: 30792310
Variant Present in the following documents:
  • Main text
View BVdb publication page



A KRAS GTPase K104Q Mutant Retains Downstream Signaling by Offsetting Defects in Regulation.

The Journal Of Biological Chemistry
Yin, Guowei G; Kistler, Samantha S; George, Samuel D SD; Kuhlmann, Nora N; Garvey, Leslie L; Huynh, Minh M; Bagni, Rachel K RK; Lammers, Michael M; Der, Channing J CJ; Campbell, Sharon L SL
Publication Date: 2017-03-17

Variant appearance in text: KRAS: K104Q
PubMed Link: 28154176
Variant Present in the following documents:
  • Main text
View BVdb publication page